Diltiazem vs Pembrolizumab

Diltiazem vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Diltiazem and Pembrolizumab.

Mechanism of Action

Diltiazem: Benzothiazepine calcium channel blocker.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Diltiazem — 3-4.5 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Diltiazem — C22H26N2O4S.

Molecular Weight: Diltiazem — 414.5190 g/mol.

Type: Diltiazem — Small molecule; Pembrolizumab — Antibody.